Upcoming Events

Research Highlights

Previous
Next

The present study prioritizes withanolide F as a prospective COVID-19 (Coronavirus disease) therapeutic agent based on the observations. 1578 compounds fltered from 9596 phytochemicals were chosen for screening against the RBD of the native SARS-CoV-2 S protein. Based on the binding energy, Four phytochemicals, namely withanolide F, serotobenine, orobanchol, and gibberellin A51, were found to be potential RBD binders in native and all SARS-CoV-2 VOCs. Interestingly withanolide F exhibited lower binding energy (-10.84 to -8.56 kcal/mol) and better ligand efciency (-0.3 to -0.25) against all forms of RBD in native and VOCs.

Impact

7
Consultancy
10
High Impact Publications
2
International Collaboration
17
Extramural Submission
2
Extramural Awarded
3
International Workshop
2
Certificate Course
2
Training

Past Events

June 27, 2022
0

Certificate Course on Data Science & Personalised Medicine

To impart learning in the breadth and depth of frontiers in fundamental and advanced sciences

May 13, 2022
0

World IP Day Program

On 26th April 2022, SBV MIPTECH and SBV MGM Bioincubator organized a one-day awareness program

X